BeaCapra CJC-1295 / Ipamorelin Blend — The Peak Stack

The Peak Stack: Premier Growth Hormone Research Combination

The BeaCapra Peak Stack combines CJC-1295 no DAC (5mg) and Ipamorelin (5mg) in a single 10mg lyophilized blend—the most widely researched growth hormone peptide combination in the field. This precision formulation targets two complementary GH release mechanisms: GHRH receptor activation (CJC-1295) and ghrelin receptor agonism (Ipamorelin). Each vial is verified at ≥99% purity by HPLC and mass spectrometry.

Published research demonstrates that combining a GHRH analog with a GH secretagogue produces synergistic GH release significantly greater than either peptide alone. CJC-1295 amplifies the GHRH pulse signal while Ipamorelin provides the ghrelin-mediated release trigger, resulting in enhanced amplitude and duration of GH pulses while maintaining the natural pulsatile release pattern.

The Peak Stack is designed for researchers investigating growth hormone axis optimization, age-related GH decline, body composition changes, and metabolic regulation. The combined formulation simplifies multi-peptide protocols and ensures consistent co-administration ratios across study cohorts.

Storage: Store lyophilized peptide at -20°C. Reconstitute with bacteriostatic water and store at 2-8°C. Use within 30 days. Protect from light.

For research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and may not be misbranded, misused, or mislabeled as such.